In order to study the disease mechanisms and screen potential therapeutics for RDH12-retinopathies, three mutant RDH12 stable HEK-293 cell lines were created; two expressing missense mutations (p.Y226C and p.A109P) and one nonsense mutation (p.S13*). Here, RDH12 is linked to retinal disorder.